T2 Biosystems, Inc.
DelistedCIK 1492674fmd_109CH5B2EVQR3GM8E9YZEZX0WBManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2012 to Sep 30, 2024, 48 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 3 | 4 | 5 | 11 | 8 | 18 | 28 | 22 | 7 |
| Net interest income | (1) | – | – | – | – | – | – | – | – | – |
| Cost of revenue | – | 2 | 7 | 12 | – | – | – | – | 21 | – |
| Gross profit | – | 1 | (3) | (7) | – | – | – | – | 1 | – |
| Research and development | 20 | 25 | 24 | 24 | 14 | 16 | 16 | 22 | 26 | 14 |
| Selling, general and administrative | 11 | 19 | 24 | 23 | 26 | 27 | 22 | 29 | 31 | 25 |
| Total operating expenses | 31 | – | – | – | – | – | – | – | – | – |
| Operating income | (31) | (43) | (51) | (54) | (45) | (52) | (41) | (43) | (55) | (50) |
| Interest expense | 1 | 2 | 4 | – | – | 7 | 6 | 8 | 6 | – |
| Interest and investment income | – | – | – | – | – | 0 | 0 | 0 | 0 | – |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 1 | (7) | (5) | (6) | (7) | (0) |
| Net income | (31) | (45) | (55) | (62) | (51) | (59) | (47) | (49) | (62) | (50) |
| Net income to common shareholders | (36) | (45) | (55) | – | – | – | – | (49) | (62) | (50) |